Ipamorelin – Selective GHRP for Research Applications
Ipamorelin is a synthetic Growth Hormone–Releasing Peptide (GHRP)
used in laboratory research to study the stimulation of growth hormone (GH) release
via the ghrelin receptor (GHSR). This peptide is known for its selective and controlled
activity on the hypothalamic–pituitary axis in research models.
Within in-vitro studies, Ipamorelin is of interest due to its targeted interaction with
ghrelin receptors, without significant involvement in cortisol- or prolactin-related pathways
that are observed with some other GHRPs. Ipamorelin is manufactured according to strict
quality standards and verified using
High-Performance Liquid Chromatography (HPLC) to ensure a purity of
≥ 99%.
Key specifications
| Specification | Value / description |
|---|---|
| Name | Ipamorelin |
| Molecular formula | C38H49N9O5 |
| Molecular weight | ≈ 711.86 Da |
| Form | Lyophilized powder |
| Purity | ≥ 99% (HPLC tested) |
| Storage conditions | Store refrigerated, protected from light and moisture |
Application & use (research only)
- Intended exclusively for in-vitro research purposes.
- Not suitable for human or veterinary consumption or medical use.
- Applicable to endocrinological and biochemical research on growth hormone release and ghrelin receptor activity.
- Lyophilized form supports stable storage and controlled laboratory handling.
